SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
PTGX

Protagonist Therapeutics, Inc (NASDAQ:PTGX)

US · Delayed Price · Currency is USD
Healthcare · Biotechnology
139.62+1.19 (+0.86%)
 
Market cap
$9.03B
Analyst consensus
Listed since
Aug 11, 2016
Insider Score
––Not scored
PTGX Insider Score

Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.

Corporate Lobbying

Government lobbying spending instances

Loading filings…

Source: U.S. Senate LDA

Corporate Lobbying

PTGX Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New PTGX patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to PTGX from public contracts

Source: USAspending.gov

Recently reported changes in PTGX holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Congressional Trades

U.S. House and Senate disclosures referencing PTGX, reported under the STOCK Act.

PoliticianChamberActionAmountDate
No congressional trades recorded for PTGX.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.